Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
Clinical Trial | ADC
HENGRUI PHARMA (01276.HK): two drugs get clinical trial approval
Tags：
HENGRUI PHARMA
01276.HK
Clinical Trial | ADC
2026-11-04
Finance
GOLDWIND (02208.HK): issues RMB 500 mln green bond at 1.98%
Finance
INGENIC (03223.HK): registration change done, capital RMB 515 mln
Finance
FS.COM (03355.HK): trustee buys 47,600 H shares under award scheme
Finance
GUOCO GROUP (00053.HK): unit signs JV for Berlayar Drive site
Finance
EMPEROR E HOTEL (00296.HK): sees interim turnaround to profit
Finance
FOSUN PHARMA (02196.HK): HLX109 cleared for Phase I trial in Australia
Finance
TONGRENTANGCARE (02667.HK): senior manager buys 100,000 shares
Finance
FOSUN PHARMA (02196.HK): FXS6837 starts Phase III trial in China
Finance
HENGRUI PHARMA (01276.HK): two drugs get clinical trial approval
Finance
CITIC FAMC (02799.HK): Dong Hong's employee director role approved
Scan QR Code
Download App
